Viatris receives FDA approval for generic Sandostatin plus 3 other milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. NVDA
2. PCG
3. AMZN
4. AAPL
5. AVGO
6. EC
7. ALNY
8. CNS
9. STLA
10. PTGX

Go back to Viatris receives FDA approval for generic Sandostatin plus 3 other milestones
(NASDAQ: VTRS) Delayed: 16.51 --0 (-0%)
Previous Close $16.51    52 Week High $ 
Open $16.51    52 Week Low $ 
Day High $16.51    P/E N/A 
Day Low $16.51    EPS $ 
Volume 5,297